Self-Management of Analgesia and Related Treatments at the End of life

Not Applicable

Completed

• Conditions: Significant pain experienced by patients approaching the end of life living within the community; Signs and Symptoms; Pain

• Registration Number: ISRCTN35327119
• Lead Sponsor: niversity of Leeds (UK)

Brief Summary

2017 Results article in https://www.ncbi.nlm.nih.gov/pubmed/29265004 results

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-07-28
• Study Completion: 2016-08-30
• Last Update Posted: 19 April 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 81

Inclusion Criteria

Patients will be included if they are:
1. Approaching the end of life - defined as patients with an incurable advanced disease, considered to be within the last year of life
2. Experiencing significant pain: assessed using Brief Pain Inventory (BPI) and defined as a score of =>4/10 pain severity sub-scale and =>4/10 pain impact sub-scale
3. Treated with, or starting, opioid analgesia
4. Experiencing, or anticipating, adverse effects of nausea, constipation and drowsiness
5. Living at home and being cared for by specialist palliative care services in West Yorkshire and Hampshire.

Staff will be included if they are:
1. Clinical Nurse Specialists (CNSs) part of a community palliative care team
2. Service providers or managers of specialist palliative care services
3. Local commissioners of palliative care services
4. Working within palliative care services in West Yorkshire and Hampshire

Exclusion Criteria

Patients will be excluded if they lack capacity to consent to inclusion

Study & Design

• Study Type: Interventional
• Study Design: Not specified